Kalvista Pharmaceuticals Inc(KALV)_个股概要_股票价格_最新资讯_行情走势_历史数据

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

KALV Kalvista Pharmaceuticals Inc

盘前交易 08-16 04:59:21 EDT

12.79

+0.30

+2.40%

最高13.16	最低12.53	成交量17.91万
今开12.69	昨收12.49	日振幅5.00%
总市值5.47亿	流通市值2.72亿	总股本4,274万
成交额231.41万	换手率0.84%	流通股本2,125万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"KALV","market":"US","secType":"STK","nameCN":"Kalvista Pharmaceuticals Inc","latestPrice":12.79,"timestamp":1723752000000,"preClose":12.49,"halted":0,"volume":179069,"delay":0,"floatShares":21246693,"shares":42735647,"eps":-3.442668,"marketStatus":"盘前交易","marketStatusCode":1,"change":0.3,"latestTime":"08-16 04:59:21 EDT","open":12.69,"high":13.155,"low":12.53,"amount":2314114.596277,"amplitude":0.05004,"askPrice":16.02,"askSize":10,"bidPrice":5.12,"bidSize":200,"shortable":3,"etf":0,"ttmEps":-3.442668,"exchange":"NASDAQ","tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1723815000000},"adr":0,"listingDate":1479790800000,"adjPreClose":12.79,"adrRate":0,"postHourTrading":{"tag":"盘后","latestPrice":12.79,"preClose":12.79,"latestTime":"16:02 EDT","volume":4184,"amount":53513.36,"timestamp":1723752164914},"volumeRatio":1.4013128125003373,"impliedVol":0.8975,"impliedVolPercentile":0.3586},"requestUrl":"/m/hq/s/KALV","defaultTab":"news","newsList":[{"id":"2459959408","title":"Kalvista Pharmaceuticals, Inc.盘中异动 大幅拉升5.12%报13.13美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2459959408","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459959408?lang=zh_cn&edition=full","pubTime":"2024-08-16 00:46","pubTimestamp":1723740383,"startTime":"0","endTime":"0","summary":"北京时间2024年08月16日00时46分，Kalvista Pharmaceuticals, Inc.股票出现异动，股价急速拉升5.12%。Kalvista Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为1.47%。其相关个股中，Cingulate Inc.、Nutriband Inc C/Wts 、Tempest Therapeutics, Inc.涨幅较大，Cingulate Inc.、Scisparc Ltd.、Altamira Therapeutics Ltd.较为活跃，换手率分别为7847.47%、2251.32%、621.92%，振幅较大的相关个股有Nls Pharmaceutics Ltd C/Wts 02/02/2026、Nutriband Inc C/Wts 、Seastar Medical Holding Corp C/Wts 28/10/2027 ，振幅分别为163.00%、115.79%、103.98%。Kalvista Pharmaceuticals, Inc.公司简介：KalVista Pharmaceuticals Inc 是一家专注于发现、开发和商业化用于一系列疾病的小分子蛋白酶抑制剂的制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240816004624a1d47664&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240816004624a1d47664&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","KALV"],"gpt_icon":0},{"id":"2458034090","title":"Kalvista Pharmaceuticals, Inc.盘中异动 下午盘股价大涨5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2458034090","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458034090?lang=zh_cn&edition=full","pubTime":"2024-08-09 01:43","pubTimestamp":1723138994,"startTime":"0","endTime":"0","summary":"北京时间2024年08月09日01时43分，Kalvista Pharmaceuticals, Inc.股票出现波动，股价大幅上涨5.04%。Kalvista Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为3.17%。其相关个股中，Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Senti Biosciences, Inc.、Aldeyra Therapeutics, Inc.涨幅较大，Conduit Pharmaceuticals Inc.、Anew Medical, Inc.、Aditxt, Inc.较为活跃，换手率分别为424.96%、296.53%、199.25%，振幅较大的相关个股有Conduit Pharmaceuticals Inc.、Oragenics Inc.、Fibrobiologics, Inc.，振幅分别为131.52%、54.41%、45.58%。Kalvista Pharmaceuticals, Inc.公司简介：KalVista Pharmaceuticals Inc 是一家专注于发现、开发和商业化用于一系列疾病的小分子蛋白酶抑制剂的制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240809014314941ff831&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240809014314941ff831&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KALV","BK4139"],"gpt_icon":0},{"id":"2457670773","title":"Kalvista Pharmaceuticals, Inc.盘中异动 股价大跌7.82%","url":"https://stock-news.laohu8.com/highlight/detail?id=2457670773","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457670773?lang=zh_cn&edition=full","pubTime":"2024-08-05 21:38","pubTimestamp":1722865081,"startTime":"0","endTime":"0","summary":"北京时间2024年08月05日21时38分，Kalvista Pharmaceuticals, Inc.股票出现波动，股价快速跳水7.82%。Kalvista Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为1.94%。其相关个股中，Zevra Therapeutics, Inc.、Rocket Pharmaceuticals Inc C/Wts 02/09/2026 、Oculis Holding Ag C/Wts 06/03/2028 涨幅较大，Cns Pharmaceuticals, Inc.、Dermata Therapeutics, Inc.、Senti Biosciences, Inc.较为活跃，换手率分别为1065.46%、51.14%、14.09%，振幅较大的相关个股有Alterity Therapeutics Limited、Cns Pharmaceuticals, Inc.、60 Degrees Pharmaceuticals, Inc.，振幅分别为20.00%、19.99%、17.59%。Kalvista Pharmaceuticals, Inc.公司简介：KalVista Pharmaceuticals Inc 是一家专注于发现、开发和商业化用于一系列疾病的小分子蛋白酶抑制剂的制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408052138029f1072ed&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408052138029f1072ed&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KALV","BK4139"],"gpt_icon":0},{"id":"2456450045","title":"Kalvista Pharmaceuticals, Inc.盘中异动 股价大跌5.02%报13.81美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2456450045","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456450045?lang=zh_cn&edition=full","pubTime":"2024-08-02 02:38","pubTimestamp":1722537489,"startTime":"0","endTime":"0","summary":"北京时间2024年08月02日02时38分，Kalvista Pharmaceuticals, Inc.股票出现波动，股价快速下跌5.02%。Kalvista Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.85%。其相关个股中，Dermata Therapeutics, Inc.、Nls Pharmaceutics Ltd C/Wts 02/02/2026、Coeptis Therapeutics Holdings Inc C/Wts 31/12/2024 涨幅较大，Dermata Therapeutics, Inc.、Windtree Therapeutics, Inc.、Immuneering Corporation较为活跃，换手率分别为2837.22%、372.43%、218.22%，振幅较大的相关个股有Dermata Therapeutics, Inc.、Renovaro Inc.、Virax Biolabs Group Limited，振幅分别为59.30%、57.88%、43.37%。Kalvista Pharmaceuticals, Inc.公司简介：KalVista Pharmaceuticals Inc 是一家专注于发现、开发和商业化用于一系列疾病的小分子蛋白酶抑制剂的制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240802023809af956791&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240802023809af956791&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KALV","BK4139"],"gpt_icon":0},{"id":"2452717436","title":"Kalvista Pharmaceuticals, Inc.盘中异动 临近午盘股价大跌5.01%报14.22美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2452717436","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2452717436?lang=zh_cn&edition=full","pubTime":"2024-07-18 23:53","pubTimestamp":1721318029,"startTime":"0","endTime":"0","summary":"北京时间2024年07月18日23时53分，Kalvista Pharmaceuticals, Inc.股票出现波动，股价大幅下挫5.01%。Kalvista Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为2.02%。其相关个股中，Onconetix, Inc.、Silo Pharma, Inc.、Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 涨幅较大，Silo Pharma, Inc.、Salarius Pharmaceuticals, Inc.、Onconetix, Inc.较为活跃，换手率分别为2241.57%、2080.70%、1179.54%，振幅较大的相关个股有Silo Pharma, Inc.、Salarius Pharmaceuticals, Inc.、Onconetix, Inc.，振幅分别为93.33%、91.50%、86.24%。Kalvista Pharmaceuticals, Inc.公司简介：KalVista Pharmaceuticals Inc 是一家制药公司，专注于发现、开发和商业化用于一系列疾病的小分子蛋白酶抑制剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240718235349aefa5a66&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240718235349aefa5a66&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","KALV"],"gpt_icon":0},{"id":"2451626886","title":"Kalvista Pharmaceuticals, Inc.盘中异动 快速上涨5.14%报13.71美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2451626886","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2451626886?lang=zh_cn&edition=full","pubTime":"2024-07-15 22:08","pubTimestamp":1721052536,"startTime":"0","endTime":"0","summary":"北京时间2024年07月15日22时08分，Kalvista Pharmaceuticals, Inc.股票出现波动，股价快速上涨5.14%。Kalvista Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.43%。Kalvista Pharmaceuticals, Inc.公司简介：KalVista Pharmaceuticals Inc 是一家制药公司，专注于发现、开发和商业化用于一系列疾病的小分子蛋白酶抑制剂。消息层面，截至22时08分，《Needham维持KalVista Pharmaceuticals买入评级，下调目标价至32美元》资讯为影响Kalvista Pharmaceuticals, Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407152208569681cd37&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407152208569681cd37&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KALV","BK4139"],"gpt_icon":0},{"id":"2450535689","title":"Kalvista Pharmaceuticals, Inc.盘中异动 早盘大幅上涨5.76%","url":"https://stock-news.laohu8.com/highlight/detail?id=2450535689","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2450535689?lang=zh_cn&edition=full","pubTime":"2024-07-12 21:32","pubTimestamp":1720791121,"startTime":"0","endTime":"0","summary":"北京时间2024年07月12日21时32分，Kalvista Pharmaceuticals, Inc.股票出现异动，股价大幅拉升5.76%。Kalvista Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.57%。Kalvista Pharmaceuticals, Inc.公司简介：KalVista Pharmaceuticals Inc 是一家制药公司，专注于发现、开发和商业化用于一系列疾病的小分子蛋白酶抑制剂。消息层面，截至21时32分，《Needham维持KalVista Pharmaceuticals买入评级，下调目标价至32美元》资讯为影响Kalvista Pharmaceuticals, Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240712213202aef97a4b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240712213202aef97a4b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","KALV"],"gpt_icon":0},{"id":"2450372033","title":"美国研究综述：波士顿啤酒公司、Inter Parfums、Netflix","url":"https://stock-news.laohu8.com/highlight/detail?id=2450372033","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2450372033?lang=zh_cn&edition=full","pubTime":"2024-07-12 15:46","pubTimestamp":1720770376,"startTime":"0","endTime":"0","summary":"    路透7月12日 - 华尔街证券分析师周五修订了对波士顿啤酒公司、Inter Parfums 和 Netflix 等几家美国上市公司的评级和目标价。亮点             * 波士顿啤酒公司  ：Piper Sandler 将该公司的目标价从 350 美元下调至 344 美元              * Inter Parfums Inc   ：杰富瑞将其评级从 \"持有 \"上调至 \"买入              * Netflix Inc   ：摩根大通将目标价从650美元上调至750美元              * Smurfit Westrock   ：摩根大通将该股列入分析师关注名单              * Vita Coco Company Inc   ：Piper Sandler将其评级从 \"增持 \"下调至 \"中性\"。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CPAY","LU0786609619.USD","COCO","BK4548","EL","WES","WPC","YMAB","BK4201","BK4209","OXY","BK4550","LU1303367103.USD","PNTG","IDYA","CAG","SCHW","SAGE","ZLAB","SAM","BK4146","BK4127","BSVN","KALV","BK4009","PTLO","BK4108","BK4566","PEP","IPG","LU2360107671.USD","LU1153585028.USD","NKE","WEX","LU0234572021.USD","BK4558","LU1861220207.SGD","LU2098885051.SGD","BK4177","SG9999004303.SGD","NFLX","LU1046421795.USD","SW","LU0266013472.USD","SG9999001077.SGD","CPT","IE00B19Z8W00.USD","LU1861217088.USD","IPAR","MEI"],"gpt_icon":0},{"id":"2450365782","title":"KalVista Pharma(KALV.US)：2024年Q4财报实现营收0美元，前值为0美元；每股收益为-1.02美元，前值为-0.","url":"https://stock-news.laohu8.com/highlight/detail?id=2450365782","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2450365782?lang=zh_cn&edition=full","pubTime":"2024-07-11 22:08","pubTimestamp":1720706931,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4139","KALV"],"gpt_icon":0},{"id":"2450355739","title":"卡尔维斯塔制药公司公布截至四月的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2450355739","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2450355739?lang=zh_cn&edition=full","pubTime":"2024-07-11 19:44","pubTimestamp":1720698295,"startTime":"0","endTime":"0","summary":"   * Kalvista Pharmaceuticals Inc   报告，截至4月底的季度调整后每股亏损1.02美元，低于去年同期的每股收益-77美分。六位分析师对该季度的平均预期是每股亏损 73 美分。华尔街预期为每股-84美分至-55美分。* Kalvista Pharmaceuticals Inc 公布的季度每股收益为亏损 1.02 美元。* 该公司当季亏损 4465 万美元。* Kalvista Pharmaceuticals Inc 的股价本季度上涨了 6.7%，今年迄今为止上涨了 2.6%。* 医药同行的平均一致建议是 \"买入\"。华尔街对 Kalvista Pharmaceuticals Inc 的 12 个月目标价中位数为 35.00 美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KALV","BK4139"],"gpt_icon":0},{"id":"2448028321","title":"Kalvista Pharmaceuticals Inc   预计每股亏损73美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2448028321","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2448028321?lang=zh_cn&edition=full","pubTime":"2024-07-03 20:32","pubTimestamp":1720009941,"startTime":"0","endTime":"0","summary":"   * Kalvista Pharmaceuticals Inc    预计在7月5日公布截至2024年4月30日的业绩时，季度收入将没有变化(预计)。*    * LSEG分析师对Kalvista Pharmaceuticals Inc的平均预期是每股亏损73美分。* 华尔街对 Kalvista Pharmaceuticals Inc 的 12 个月目标价中位数为 35.00 美元，高于其最新收盘价 11.51 美元。7月3日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。(如对本报告中的数据有任何疑问，请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KALV"],"gpt_icon":0},{"id":"2446721564","title":"Kalvista Pharmaceuticals, Inc.盘中异动 股价大涨5.04%报11.88美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2446721564","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2446721564?lang=zh_cn&edition=full","pubTime":"2024-06-28 02:51","pubTimestamp":1719514315,"startTime":"0","endTime":"0","summary":"北京时间2024年06月28日02时51分，Kalvista Pharmaceuticals, Inc.股票出现波动，股价大幅上涨5.04%。Kalvista Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.48%。其相关个股中，Geovax Labs Inc C/Wts 29/09/2025、Geovax Labs, Inc.、180 Life Sciences Corp C/Wts 07/11/2025涨幅较大，Geovax Labs, Inc.、Kala Bio, Inc.、Nls Pharmaceutics Ltd.较为活跃，换手率分别为2974.81%、388.31%、363.06%，振幅较大的相关个股有Geovax Labs Inc C/Wts 29/09/2025、Geovax Labs, Inc.、Nls Pharmaceutics Ltd.，振幅分别为322.04%、127.05%、96.88%。Kalvista Pharmaceuticals, Inc.公司简介：KalVista Pharmaceuticals Inc 是一家制药公司，专注于发现、开发和商业化用于一系列疾病的小分子蛋白酶抑制剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240628025155968178ee&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240628025155968178ee&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KALV","BK4139"],"gpt_icon":0},{"id":"2446313088","title":"Kalvista Pharmaceuticals, Inc.盘中异动 急速下挫5.02%报10.97美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2446313088","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2446313088?lang=zh_cn&edition=full","pubTime":"2024-06-27 00:24","pubTimestamp":1719419052,"startTime":"0","endTime":"0","summary":"北京时间2024年06月27日00时24分，Kalvista Pharmaceuticals, Inc.股票出现波动，股价快速下跌5.02%。Kalvista Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为1.00%。其相关个股中，Anew Medical, Inc.、Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 、Diamedica Therapeutics Inc.涨幅较大，Anew Medical, Inc.、Cns Pharmaceuticals, Inc.、Gri Bio, Inc.较为活跃，换手率分别为674.37%、152.94%、108.23%，振幅较大的相关个股有Anew Medical, Inc.、Effector Therapeutics Inc C/Wts 31/12/2025 、Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 ，振幅分别为112.12%、51.85%、45.14%。Kalvista Pharmaceuticals, Inc.公司简介：KalVista Pharmaceuticals Inc 是一家制药公司，专注于发现、开发和商业化用于一系列疾病的小分子蛋白酶抑制剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240627002412aef6c22c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240627002412aef6c22c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KALV","BK4139"],"gpt_icon":0},{"id":"2445794947","title":"Kalvista Pharmaceuticals, Inc.盘中异动 临近收盘股价大涨5.00%报11.77美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2445794947","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2445794947?lang=zh_cn&edition=full","pubTime":"2024-06-22 03:56","pubTimestamp":1718999777,"startTime":"0","endTime":"0","summary":"北京时间2024年06月22日03时56分，Kalvista Pharmaceuticals, Inc.股票出现异动，股价快速上涨5.00%。截至发稿，该股报11.77美元/股，成交量23.3059万股，换手率0.55%，振幅3.93%。Kalvista Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.21%。Kalvista Pharmaceuticals, Inc.公司简介：KalVista Pharmaceuticals Inc 是一家制药公司，专注于发现、开发和商业化用于一系列疾病的小分子蛋白酶抑制剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024062203561896815d76&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024062203561896815d76&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","KALV"],"gpt_icon":0},{"id":"2444579100","title":"Kalvista Pharmaceuticals Inc：计划在2024年向其他全球货币健康机构提交额外的营销授权申请。","url":"https://stock-news.laohu8.com/highlight/detail?id=2444579100","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2444579100?lang=zh_cn&edition=full","pubTime":"2024-06-18 18:30","pubTimestamp":1718706626,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4139","KALV"],"gpt_icon":0},{"id":"2432595131","title":"HC Wainwright & Co.：维持KalVista Pharma(KALV.US)评级，由买入调整至买入评级, 目标价由24.00美元调整至20.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2432595131","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2432595131?lang=zh_cn&edition=full","pubTime":"2024-05-04 03:55","pubTimestamp":1714766108,"startTime":"0","endTime":"0","summary":"HC Wainwright & Co.：维持KalVista Pharma(KALV.US)评级，由买入调整至买入评级, 目标价由24.00美元调整至20.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050403551287cf5485&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050403551287cf5485&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KALV"],"gpt_icon":0},{"id":"2432135043","title":"HC Wainwright &amp; Co.：维持KalVista Pharma(KALV.US)评级，由买入调整至买入评级, 目标价由24.","url":"https://stock-news.laohu8.com/highlight/detail?id=2432135043","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2432135043?lang=zh_cn&edition=full","pubTime":"2024-05-04 03:44","pubTimestamp":1714765449,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4139","KALV"],"gpt_icon":0},{"id":"2432503594","title":"Kalvista Pharmaceuticals, Inc.盘中异动 早盘股价大涨5.11%报11.93美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2432503594","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2432503594?lang=zh_cn&edition=full","pubTime":"2024-05-01 22:07","pubTimestamp":1714572448,"startTime":"0","endTime":"0","summary":"北京时间2024年05月01日22时07分，Kalvista Pharmaceuticals, Inc.股票出现波动，股价快速拉升5.11%。Kalvista Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.13%。其相关个股中，Cytomx Therapeutics, Inc.、Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Brainstorm Cell Therapeutics Inc.涨幅较大，Palisade Bio, Inc.、Cytomx Therapeutics, Inc.、Cyclacel Pharmaceuticals, Inc.较为活跃，换手率分别为1098.40%、99.14%、30.79%，振幅较大的相关个股有Cytomx Therapeutics, Inc.、Promis Neurosciences Inc.、Palisade Bio, Inc.，振幅分别为86.50%、30.95%、30.85%。Kalvista Pharmaceuticals, Inc.公司简介：KalVista Pharmaceuticals Inc 是一家制药公司，专注于发现、开发和商业化用于一系列疾病的小分子蛋白酶抑制剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405012207287925a1b1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405012207287925a1b1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KALV","BK4139"],"gpt_icon":0},{"id":"2426232644","title":"Needham：重申KalVista Pharma(KALV.US)评级，由买入调整至买入评级, 目标价35.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2426232644","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2426232644?lang=zh_cn&edition=full","pubTime":"2024-04-11 18:15","pubTimestamp":1712830514,"startTime":"0","endTime":"0","summary":"Needham：重申KalVista Pharma(KALV.US)评级，由买入调整至买入评级, 目标价35.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404111815198b0fb8cf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404111815198b0fb8cf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KALV"],"gpt_icon":0},{"id":"2426823484","title":"Needham：重申KalVista Pharma(KALV.US)评级，由买入调整至买入评级, 目标价35.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2426823484","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2426823484?lang=zh_cn&edition=full","pubTime":"2024-04-11 18:07","pubTimestamp":1712830049,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["KALV","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.kalvista.com","stockEarnings":[{"period":"1week","weight":-0.0199},{"period":"1month","weight":-0.1613},{"period":"3month","weight":0.073},{"period":"6month","weight":-0.1393},{"period":"1year","weight":0.1865},{"period":"ytd","weight":0.0441}],"compareEarnings":[{"period":"1week","weight":0.0423},{"period":"1month","weight":-0.0209},{"period":"3month","weight":0.0446},{"period":"6month","weight":0.1072},{"period":"1year","weight":0.258},{"period":"ytd","weight":0.1636}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"KalVista Pharmaceuticals, Inc.于2004年3月26日在特拉华州注册成立。该公司是一家临床阶段制药公司，专注于发现、开发和商业化小分子蛋白酶抑制剂，用于有重大未满足需求的疾病。该公司运用他们对蛋白酶的化学和生物学的洞见，开发出具有高选择性、效力和生物利用度的口服疗法，该公司相信这将使它们成为治疗疾病的成功药物。该公司利用这些能力开发了针对遗传性血管性水肿（HAE）的新型小分子血浆激肽释放酶抑制剂。该公司还在进行一项新的口服XIIa因子（“XIIa因子”）抑制剂项目的临床前开发。该公司正在初步推进这一项目，以提供下一代HAE疗法，这也为将来扩展到其他未满足的高需求适应症提供了机会。","yearOnYearQuotes":[{"month":1,"riseRate":0.375,"avgChangeRate":0.011211},{"month":2,"riseRate":0.5,"avgChangeRate":0.168896},{"month":3,"riseRate":0.375,"avgChangeRate":-0.068789},{"month":4,"riseRate":0.375,"avgChangeRate":0.010157},{"month":5,"riseRate":0.5,"avgChangeRate":-0.027585},{"month":6,"riseRate":0.625,"avgChangeRate":-0.000971},{"month":7,"riseRate":0.5,"avgChangeRate":0.018821},{"month":8,"riseRate":0.625,"avgChangeRate":0.164439},{"month":9,"riseRate":0.285714,"avgChangeRate":-0.051841},{"month":10,"riseRate":0.428571,"avgChangeRate":0.041215},{"month":11,"riseRate":0.571429,"avgChangeRate":0.052624},{"month":12,"riseRate":0.5,"avgChangeRate":0.066364}],"exchange":"NASDAQ","name":"Kalvista Pharmaceuticals Inc","nameEN":"Kalvista Pharmaceuticals Inc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.26.2","shortVersion":"4.26.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Kalvista Pharmaceuticals Inc(KALV)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Kalvista Pharmaceuticals Inc(KALV)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Kalvista Pharmaceuticals Inc,KALV,Kalvista Pharmaceuticals Inc股票,Kalvista Pharmaceuticals Inc股票老虎,Kalvista Pharmaceuticals Inc股票老虎国际,Kalvista Pharmaceuticals Inc行情,Kalvista Pharmaceuticals Inc股票行情,Kalvista Pharmaceuticals Inc股价,Kalvista Pharmaceuticals Inc股市,Kalvista Pharmaceuticals Inc股票价格,Kalvista Pharmaceuticals Inc股票交易,Kalvista Pharmaceuticals Inc股票购买,Kalvista Pharmaceuticals Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Kalvista Pharmaceuticals Inc(KALV)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Kalvista Pharmaceuticals Inc(KALV)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}

公司概况